Form 4 for HCAT Health Catalyst, Inc.
Accepted 2021-08-12 00:00:00 ET · period of report 2021-08-10 · accession 0001562180-21-005302 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2021-08-12 | 2021-08-10 | HCAT | Hinton Bryan Richard | CTO | M - OptEx | $10.79 | +1,828 | 24.6K | +8% | +$19.7K |
| DM | 2021-08-12 | 2021-08-10 | HCAT | Hinton Bryan Richard | CTO | S - Sale+OE | $54.31 | -4,020 | 23.9K | -14% | -$218.3K |
| DM | 2021-08-12 | 2021-08-10 | HCAT | Hinton Bryan Richard | CTO | M - OptEx | $0.00 | -1,828 | 952 | -66% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2021-08-10 | M | A | 1,300 | $10.80 | 25,895 | D | — | — | |
| 2 | Common | Common Stock | 2021-08-10 | S | D | 658 | $52.91 | 25,237 | D | — | — | (F2) Represents a weighted average price. These shares were sold by the Reporting Person in multiple transactions at prices ranging from $52.28 to $53.13, inclusive. |
| 3 | Common | Common Stock | 2021-08-10 | S | D | 1,327 | $54.65 | 22,600 | D | — | — | (F4) Represents a weighted average price. These shares were sold by the Reporting Person in multiple transactions at prices ranging from $54.48 to $54.82, inclusive. |
| 4 | Common | Common Stock | 2021-08-10 | S | D | 725 | $55.51 | 21,875 | D | — | — | (F5) Represents a weighted average price. These shares were sold by the Reporting Person in multiple transactions at prices ranging from $55.51 to $55.52, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in Footnotes (2) through (5). |
| 5 | Common | Common Stock | 2021-08-10 | M | A | 528 | $10.78 | 24,595 | D | — | — | |
| 6 | Common | Common Stock | 2021-08-10 | S | D | 1,310 | $54.02 | 23,927 | D | — | — | (F3) Represents a weighted average price. These shares were sold by the Reporting Person in multiple transactions at prices ranging from $53.47 to $54.38, inclusive. |
| 7 | Derivative | Stock Option (Right to Buy) | 2021-08-10 | M | D | 1,300 | $0.00 | 3,640 | D | $10.80 · — to 2028-09-27 | 1,300 Common Stock | (F6) 25% of the 12,500 shares underlying the option vested in an annual installment and the remaining balance vested or will vest in equal monthly installments until the option vests in full on September 25, 2022. |
| 8 | Derivative | Stock Option (Right to Buy) | 2021-08-10 | M | D | 528 | $0.00 | 952 | D | $10.78 · — to 2028-05-03 | 528 Common Stock | (F7) 25% of the 5,082 shares underlying the option vested in an annual installment and the remaining balance vested or will vest in equal monthly installments until the option vests in full on May 3, 2022. |